Publication | Open Access

The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel’s active metabolite

Molecular PharmacologyThrombosisEfficient GenerationBiochemistryBlood PlateletVivo Antiplatelet EffectsMedicinePharmacotherapySimilar Antiplatelet ActivityPlatelet AntagonistPharmacology